Publicacións nas que colabora con Alejandro Sánchez Barreiro (19)

2014

  1. Biodistribution and lymph node retention of polysaccharide-based immunostimulating nanocapsules

    Vaccine, Vol. 32, Núm. 15, pp. 1685-1692

  2. Highly versatile immunostimulating nanocapsules for specific immune potentiation

    Nanomedicine, Vol. 9, Núm. 15, pp. 2273-2289

2013

  1. A Polymer/Oil Based Nanovaccine as a Single-Dose Immunization Approach

    PLoS ONE, Vol. 8, Núm. 4

  2. Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: A needle-free vaccination strategy

    Journal of Controlled Release, Vol. 172, Núm. 3, pp. 773-781

2012

  1. Exploring the efficiency of gallic acid-based dendrimers and their block copolymers with PEG as gene carriers

    Nanomedicine, Vol. 7, Núm. 11, pp. 1667-1681

2010

  1. Hyaluronic acid/chitosan-g-poly(ethylene glycol) nanoparticles for gene therapy: An application for p DNA and siRNA delivery

    Pharmaceutical Research, Vol. 27, Núm. 12, pp. 2544-2555

  2. Chitosan-based nanoparticles for improving immunization against hepatitis B infection

    Vaccine, Vol. 28, Núm. 14, pp. 2607-2614

  3. Chitosan-based nanostructures: A delivery platform for ocular therapeutics

    Advanced Drug Delivery Reviews, Vol. 62, Núm. 1, pp. 100-117

  4. Core-shell dendriplexes with sterically induced stoichiometry for gene delivery

    Macromolecules, Vol. 43, Núm. 17, pp. 6953-6961

  5. Preparation of poly(lactic acid) (PLA) and poly(ethylene oxide) (PEO) nanoparticles as carriers for gene delivery

    Cold Spring Harbor Protocols, Vol. 5, Núm. 8

  6. Surface-modified PLGA-based nanoparticles that can efficiently associate and deliver virus-like particles

    Nanomedicine, Vol. 5, Núm. 6, pp. 843-853

2009

  1. Chitosan nanoparticles for drug delivery to the eye

    Expert Opinion on Drug Delivery, Vol. 6, Núm. 3, pp. 239-253

2005

  1. Erratum: Chitosan Nanoparticles as New Ocular Drug Delivery Systems: In Vitro Stability, in Vivo Fate, and Cellular Toxicity (Pharmaceutical Research (2004) 21 (803-810))

    Pharmaceutical Research

2002

  1. Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats

    Current Eye Research, Vol. 24, Núm. 1, pp. 39-45

1996

  1. Erratum: Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A (Pharmaceutical Research, 13(2), 311-315, (1996))

    Pharmaceutical Research

1995

  1. Los copolímeros de ácido láctico y glicólico: características y aplicaciones en la liberación de macromoléculas

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 1, pp. 69-76

1994

  1. CICLOSPRINA A: LIMITACIONES EN SU UTILIZACION CLINICA Y NUEVAS FORMAS DE ADMINISTRACION

    Farmacia Clinica, Vol. 11, Núm. 8, pp. 675-686

  2. Los polianhídridos: características y aplicaciones en la liberación controlada de moléculas activas

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 6, pp. 83-90

1991

  1. SISTEMAS DE LIBERACION CONTROLADA DE FARMACOS A BASE DE POLIMEROS Y COPOLIMEROS DE LOS ACIDOS LACTICO Y GLICOLICO

    Farmacia Clinica, Vol. 8, Núm. 9, pp. 824-842